US$ 21.83
clinical trials for retatrutide Eli Lilly infiltrates anti-obesity market as Phase III trial begins Retatrutide Phase 1 Trials |
Description
doi: 10.1186/s12903-022-02503-9 167 FengHStockwellBR

Neither compound showed unexpected serious adverse events in isolation during clinical trials lasting up to 48 weeks

[DOI] [PubMed] [Google Scholar] 20.Smith N.K., Hackett T.A., Galli A., Flynn C.R

This is why I want you asking: Is this intended as a long-term medication for me

Slc12a8 is a nicotinamide mononucleotide transporter
